DINSHAH GAGRAT: Open Payments
NPI 1194740068 · WAUWATOSA, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$317 in 17 payments from 7 companies in 2025. Trend: 2023 $198 · 2024 $357 · 2025 $317
Food & beverage: $317
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 4 | $83 |
| Janssen Pharmaceuticals, Inc | 4 | $70 |
| ABBVIE INC. | 3 | $50 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $45 |
| Lundbeck LLC | 1 | $28 |
| E.R. Squibb & Sons, L.L.C. | 1 | $22 |
| Alkermes, Inc. | 1 | $19 |
Products named: INGREZZA, SPRAVATO, VRAYLAR, CAPLYTA, REXULTI, COBENFY, ARISTADA.
Industry payments across WI — which companies pay providers there.
